Guggenheim Capital LLC Novo Nordisk A S Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Guggenheim Capital LLC holds 28,547 shares of NVO stock, worth $2.49 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
28,547
Previous 35,408 19.38%
Holding current value
$2.49 Million
Previous $5.05 Million 32.75%
% of portfolio
0.02%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$119.07 - $145.42 $816,939 - $997,726
-6,861 Reduced 19.38%
28,547 $3.4 Million
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $312,419 - $374,032
2,546 Added 7.75%
35,408 $5.05 Million
Q1 2024

May 14, 2024
SELL
$102.11 - $135.92 $49,931 - $66,464
-489 Reduced 1.47%
32,862 $4.22 Million
Q4 2023

Feb 14, 2024
SELL
$87.78 - $105.45 $843,916 - $1.01 Million
-9,614 Reduced 22.38%
33,351 $3.45 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $1.88 Million - $4.12 Million
20,625 Added 92.32%
42,965 $3.91 Million
Q2 2023

Aug 11, 2023
SELL
$155.98 - $172.65 $875,827 - $969,429
-5,615 Reduced 20.09%
22,340 $3.62 Million
Q1 2023

May 10, 2023
BUY
$132.34 - $159.14 $905,867 - $1.09 Million
6,845 Added 32.43%
27,955 $4.45 Million
Q4 2022

Feb 14, 2023
SELL
$102.55 - $135.33 $153,004 - $201,912
-1,492 Reduced 6.6%
21,110 $2.86 Million
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $49,355 - $60,569
518 Added 2.35%
22,602 $2.25 Million
Q2 2022

Aug 15, 2022
BUY
$103.24 - $121.81 $106,233 - $125,342
1,029 Added 4.89%
22,084 $2.46 Million
Q1 2022

May 16, 2022
BUY
$93.1 - $112.54 $72,152 - $87,218
775 Added 3.82%
21,055 $2.34 Million
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $187,445 - $228,891
-1,955 Reduced 8.79%
20,280 $2.27 Million
Q3 2021

Nov 15, 2021
BUY
$84.42 - $106.62 $70,406 - $88,921
834 Added 3.9%
22,235 $2.14 Million
Q2 2021

Aug 13, 2021
SELL
$67.66 - $84.76 $85,183 - $106,712
-1,259 Reduced 5.56%
21,401 $1.79 Million
Q1 2021

May 13, 2021
BUY
$67.06 - $75.82 $14,350 - $16,225
214 Added 0.95%
22,660 $1.53 Million
Q4 2020

Feb 16, 2021
SELL
$63.89 - $73.8 $679,470 - $784,863
-10,635 Reduced 32.15%
22,446 $1.57 Million
Q3 2020

Nov 13, 2020
SELL
$63.69 - $70.22 $192,089 - $211,783
-3,016 Reduced 8.36%
33,081 $2.3 Million
Q2 2020

Aug 14, 2020
BUY
$58.54 - $67.94 $56,783 - $65,901
970 Added 2.76%
36,097 $2.36 Million
Q1 2020

Jun 02, 2020
SELL
$49.46 - $64.78 $359,475 - $470,821
-7,268 Reduced 17.14%
35,127 $2.12 Million
Q4 2019

Feb 14, 2020
SELL
$49.86 - $58.26 $754,581 - $881,706
-15,134 Reduced 26.31%
42,395 $2.45 Million
Q3 2019

Nov 14, 2019
SELL
$47.54 - $53.43 $499,883 - $561,816
-10,515 Reduced 15.45%
57,529 $2.97 Million
Q2 2019

Aug 14, 2019
SELL
$46.79 - $52.47 $852,654 - $956,160
-18,223 Reduced 21.12%
68,044 $3.47 Million
Q1 2019

May 15, 2019
BUY
$46.36 - $52.63 $760,999 - $863,921
16,415 Added 23.5%
86,267 $4.51 Million
Q4 2018

Feb 14, 2019
BUY
$41.54 - $47.25 $265,772 - $302,305
6,398 Added 10.08%
69,852 $3.22 Million
Q3 2018

Nov 14, 2018
SELL
$46.76 - $51.24 $28,383 - $31,102
-607 Reduced 0.95%
63,454 $2.99 Million
Q2 2018

Aug 14, 2018
SELL
$44.29 - $50.42 $485,639 - $552,855
-10,965 Reduced 14.61%
64,061 $2.95 Million
Q1 2018

May 15, 2018
SELL
$48.49 - $58.14 $169,666 - $203,431
-3,499 Reduced 4.46%
75,026 $3.7 Million
Q4 2017

Feb 14, 2018
BUY
$47.53 - $53.73 $430,098 - $486,202
9,049 Added 13.02%
78,525 $4.21 Million
Q3 2017

Nov 14, 2017
BUY
$41.15 - $49.22 $2.86 Million - $3.42 Million
69,476
69,476 $3.35 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email